OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CARE

被引：0
|
作者：
Heron, Louise [1 ]
Chouaid, Christos [2 ]
Vergnenegre, Alain
Bischoff, Helge [3 ]
Walzer, Stefan [4 ]
机构：
[1] Mapi Values, Value Sight & Commun, Boston, MA USA
[2] Hop St Antoine, Lille, France
[3] Univ Heidelberg, Thoraxklin, D-6900 Heidelberg, Germany
[4] F Hoffmann La Roche Pharmaceut AG, Basel, Switzerland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Progression; survival; endpoints;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1447 / S1448
页数：2
相关论文
共 50 条
  • [21] Progression-free survival and one-year milestone survival as surrogates for overall survival in previously treated advanced non-small cell lung cancer
    Zhao, Shen
    Zhang, Zhonghan
    Zhang, Yaxiong
    Hong, Shaodong
    Zhou, Ting
    Yang, Yunpeng
    Fang, Wenfeng
    Zhao, Hongyun
    Zhang, Li
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (11) : 2854 - 2866
  • [22] Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
    Lee, Chee Khoon
    Brown, Chris
    Gralla, Richard J.
    Hirsh, Vera
    Thongprasert, Sumitra
    Tsai, Chun-Ming
    Tan, Eng Huat
    Ho, James Chung-Man
    Chu, Da Tong
    Zaatar, Adel
    Osorio Sanchez, Jemela Anne
    Vu Van Vu
    Au, Joseph Siu Kie
    Inoue, Akira
    Lee, Siow Ming
    Gebski, Val
    Yang, James Chih-Hsin
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (09): : 595 - 605
  • [23] Use of progression-free survival (PFS) to predict overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Halabi, S.
    Rini, B. I.
    Stadler, W. M.
    Small, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Validity and efficiency of progression-free survival (PFS)-2 as a surrogate endpoint for overall survival (OS) in advanced cancer.
    Woodford, Rachel
    Zhou, Deborah
    Kok, Peey-Sei
    Lord, Sally
    Friedlander, Michael
    Marschner, Ian
    Simes, John
    Lee, Chee Khoon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Oncogene Mutations in Non-Small Cell Lung Cancer Have Increased Progression Free Survival and Overall Survival
    Dudzinski, S.
    Chen, H.
    Cameron, B.
    Li, B.
    Chambless, L. B.
    Luo, G.
    Morales-Paliza, M.
    Thompson, R.
    Horn, L.
    York, S.
    Lovly, C. M.
    Cmelak, A.
    Kirschner, A. N.
    Attia, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E114 - E115
  • [26] An FDA analysis of the association of tumor growth rate and overall and progression-free survival in metastatic non-small cell lung cancer (NSCLC) patients.
    Gong, Yutao
    Mason, Jeremy
    Shen, Yuan-Li
    Chang, Elaine
    Kazandjian, Dickran
    Blumenthal, Gideon Michael
    Singh, Harpreet
    Theoret, Marc Robert
    Tang, Shenghui
    Pazdur, Richard
    Beaver, Julia A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Treatment patterns, overall survival (OS), and disease-free survival (DFS) in early stage non-small cell lung cancer (NSCLC) following complete resection
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S74
  • [28] Disease-free survival (DFS) as a predictor of overall survival (OS) in completely resected early stage non-small cell lung cancer (NSCLC)
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S75
  • [29] RELATIONSHIP OF PROGRESSION-FREE SURVIVAL, POST-PROGRESSION SURVIVAL AND RESPONSE WITH OVERALL SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER OF INDIVIDUAL-LEVEL
    Imai, Hisao
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    RESPIROLOGY, 2013, 18 : 85 - 85
  • [30] Correlation of circulating miRNA levels with progression-free survival (PFS) and overall survival (OS) in early-stage lung adenocarcinoma
    Grignani, Francesco
    Trombi, Riccardo
    Baglivo, Sara
    Gunnellini, Marco
    Di Carlo, Marinella
    Tofanetti, Francesca Romana
    Siggillino, Annamaria
    Metro, Giulio
    Bennati, Chiara
    Cagini, Lucio
    Puma, Francesco
    Pistola, Lorenza
    Chiari, Rita
    Ludovini, Vienna
    Crino, Lucio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345